Skip to main content

IDWeek 2022 Main banner

Tweets by IDWeek 2022

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Back

Joann K. Ban, PharmD, MSc

GlaxoSmithKline Canada Inc., Canada

Disclosure(s): GlaxoSmithKline Canada Inc.: Employee

Poster(s):

1252 - A Real-World Observational Study on HIV-Infected Patients who Switched from Nevirapine + 2 Nucleoside Reverse Transcriptase Inhibitors to Dolutegravir/Lamivudine in British Columbia, Canada
Friday, October 21, 2022
12:15 PM – 1:30 PM US ET